Acevedo, L.A.U.; Alvarenga, A.M.; Fonseca, P.F.S.; da Silva, N.K.; Cançado, R.D.; Naoum, F.A.; Dinardo, C.L.; Pereira, A.C.; Brissot, P.; Santos, P.C.J.L.
Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period. Genes 2022, 13, 118.
https://doi.org/10.3390/genes13010118
AMA Style
Acevedo LAU, Alvarenga AM, Fonseca PFS, da Silva NK, Cançado RD, Naoum FA, Dinardo CL, Pereira AC, Brissot P, Santos PCJL.
Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period. Genes. 2022; 13(1):118.
https://doi.org/10.3390/genes13010118
Chicago/Turabian Style
Acevedo, Luis Alfredo Utria, Aline Morgan Alvarenga, Paula Fernanda Silva Fonseca, Nathália Kozikas da Silva, Rodolfo Delfini Cançado, Flavio Augusto Naoum, Carla Luana Dinardo, Alexandre Costa Pereira, Pierre Brissot, and Paulo Caleb Junior Lima Santos.
2022. "Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period" Genes 13, no. 1: 118.
https://doi.org/10.3390/genes13010118
APA Style
Acevedo, L. A. U., Alvarenga, A. M., Fonseca, P. F. S., da Silva, N. K., Cançado, R. D., Naoum, F. A., Dinardo, C. L., Pereira, A. C., Brissot, P., & Santos, P. C. J. L.
(2022). Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period. Genes, 13(1), 118.
https://doi.org/10.3390/genes13010118